NYSE : OSCR

Oscar Health, Inc. — Financial statements

Healthcare · Healthcare Plans · United States

Last price 30.37 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 9.36B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Premiums & Annuity Revenue15.04B11.47B8.97B5.69B3.87B1.89B
Total Interest & Dividend Income248.23M202.94M185.73M155.45M27.59M2.30M
Other Revenue29.58M28.59M20.58M21.35M64.93M5.39M
Total Revenue15.32B11.70B9.18B5.86B3.96B1.89B
Policy Benefits12.23B10.02B7.33B4.64B3.28B1.62B
Depreciation & Amortization28.27M28.89M32.15M30.69M15.28M
Selling, General & Administrative2.43B2.05B1.76B1.43B1.26B360.16M
Other Operating Expenses368.07M
Total Operating Expenses14.69B12.10B9.12B6.10B4.55B2.44B
Operating Income629.72M-396.36M57.27M-235.62M-589.87M-544.48M
Interest Expense-15.85M-17.60M-23.73M-24.60M-22.62M-4.72M
Other Non Operating Income (Expenses)-24.06M-23.34M-105.00K-7.08M2.42M-1.20M
EBT Excluding Unusual Items589.81M-437.30M33.43M-267.30M-610.08M-550.40M
Other Unusual Items-20.18M
Pretax Income589.81M-437.30M33.43M-267.30M-610.08M-570.58M
Income Tax Expense38.88M5.61M7.30M3.29M-523.00K846.00K
Earnings From Continuing Ops.550.93M-442.90M26.12M-270.59M-609.55M-571.43M
Minority Interest in Earnings-190.00K-248.00K-689.00K-134.00K3.28M-1.18M
Net Income550.74M-443.15M25.43M-270.73M-606.27M-572.61M
Net Income to Common550.74M-443.15M25.43M-270.73M-606.27M-572.61M
Shares Outstanding (Basic)285.78M262.39M240.39M221.66M212.47M178.97M
Shares Outstanding (Diluted)292.91M262.39M265.85M221.66M212.47M178.97M
EPS (Basic)1.93-1.690.11-1.22-2.85-3.20
EPS (Diluted)1.91-1.690.10-1.22-2.85-3.20
Free Cash Flow4.38B1.06B950.30M-297.74M351.34M-207.63M
Free Cash Flow Per Share14.954.033.58-1.341.65-1.16
Operating Margin4.11%-3.39%0.62%-4.02%-14.88%-28.75%
Profit Margin3.60%-3.79%0.28%-4.62%-15.30%-30.23%
Free Cash Flow Margin28.59%9.05%10.36%-5.08%8.86%-10.96%
EBITDA657.96M-367.46M89.41M-204.92M-574.58M-529.88M
EBITDA Margin4.29%-3.14%0.97%-3.50%-14.50%-27.98%
D&A For EBITDA28.24M28.89M32.15M30.69M15.28M14.61M
EBIT629.72M-396.36M57.27M-235.62M-589.87M-544.48M
EBIT Margin4.11%-3.39%0.62%-4.02%-14.88%-28.75%
Effective Tax Rate6.59%21.85%
Revenue as Reported15.32B11.70B9.18B5.86B3.96B

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Total Investments6.08B2.69B2.44B1.06B1.62B1.43B
Cash & Equivalents4.08B2.77B1.53B1.87B1.56B1.10B
Reinsurance Recoverable196.54M99.75M291.54M241.19M892.89M431.99M
Other Receivables560.81M498.71M380.67M253.19M266.34M182.85M
Property, Plant & Equipment101.49M139.89M123.95M124.80M127.89M119.57M
Other Current Assets60.32M24.33M21.32M6.56M6.45M
Other Long-Term Assets151.31M101.13M56.12M50.27M54.24M51.68M
Total Assets11.23B6.33B4.84B3.60B4.53B3.32B
Accounts Payable525.71M633.00M418.88M259.19M285.02M219.96M
Insurance & Annuity Liabilities2.59B1.56B1.06B1.52B823.64M
Unpaid Claims1.90B1.46B1.36B965.99M937.73M513.58M
Unearned Premiums167.50M166.20M74.39M65.92M79.00M75.04M
Reinsurance Payable2.56M3.58M41.35M61.02M427.65M205.23M
Current Portion of Leases16.72M13.55M14.18M12.82M14.83M
Long-Term Debt431.63M430.10M299.56M298.78M298.00M
Long-Term Leases50.47M51.99M60.65M66.80M72.17M76.84M
Other Long-Term Liabilities3.00K631.00K771.00K105.00K
Total Liabilities9.17B5.34B3.82B2.80B3.63B1.93B
Common Stock3.00K3.00K2.00K2.00K2.00K2.00K
Additional Paid-In Capital4.32B4.26B3.87B3.68B3.51B3.39B
Retained Earnings-2.25B-3.29B-2.85B-2.88B-2.61B-2.00B
Treasury Stock-2.92M-2.92M-2.92M-2.92M-2.92M-2.92M
Comprehensive Income & Other-8.25M18.03M-1.83M1.31M-9.71M-3.67M
Total Common Equity2.05B977.65M1.01B803.97M890.38M1.39B
Minority Interest3.13M3.09M2.84M2.15M2.02M5.29M
Shareholders' Equity2.06B980.74M1.02B806.12M892.40M1.39B
Total Liabilities & Equity11.23B6.33B4.84B3.60B4.53B3.32B
Filing Date Shares Outstanding308.33M297.43M250.25M229.41M215.99M210.08M
Total Common Shares Outstanding308.27M297.37M250.17M229.07M215.98M210.01M
Total Debt482.10M498.80M373.75M379.75M383.00M91.67M
Net Cash (Debt)3.59B2.28B1.15B1.49B1.18B1.01B
Net Cash Per Share12.278.674.346.725.535.66
Book Value Per Share6.663.294.053.514.126.61
Tangible Book Value2.05B977.65M1.01B803.97M890.38M1.39B
Tangible Book Value Per Share6.663.294.053.514.126.61
Leasehold Improvements25.53M26.39M25.30M25.30M25.75M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income550.74M-443.15M25.43M-270.73M-606.27M-572.61M
Depreciation & Amortization28.24M28.89M32.15M30.69M15.28M14.61M
Other Amortization3.40M1.63M778.00K778.00K713.00K329.00K
Gain (Loss) on Sale of Investments-29.41M-29.79M-26.88M-29.37M2.48M8.03M
Stock-Based Compensation75.19M87.65M109.82M159.68M112.33M86.30M
Change in Accounts Receivable-115.71M-101.93M-114.32M-13.40M-81.05M-66.95M
Reinsurance Recoverable-3.85M191.79M-50.34M651.69M-460.90M147.40M
Change in Accounts Payable122.87M205.49M152.77M-29.18M57.81M98.62M
Change in Unearned Revenue98.02M91.81M8.47M-13.08M3.95M3.14M
Change in Insurance Reserves / Liabilities-5.78M1.56M-25.03M-55.33M
Change in Other Net Operating Assets3.65B1.11B867.74M-423.05M1.14B258.89M
Other Operating Activities5.30M14.69M-1.67M262.00K-2.17M33.90M
Operating Cash Flow4.42B1.09B978.19M-272.16M380.35M-181.75M
Capital Expenditures-38.62M-36.37M-27.90M-25.58M-29.01M-25.89M
Investment in Securities-3.29B-208.96M-1.36B605.04M-198.62M-755.30M
Other Investing Activities4.36M4.28M3.93M-2.28M1.12M6.67M
Investing Cash Flow-3.32B-241.06M-1.39B577.19M-226.52M-774.51M
Long-Term Debt Issued410.00M305.00M
Total Debt Repaid-38.88M-38.88M-153.17M
Net Debt Issued (Repaid)371.12M371.12M305.00M-153.17M
Issuance of Common Stock55.64M55.03M68.39M6.45M3.15M1.41B
Repurchases of Common Stock-13.67M-4.04M
Other Financing Activities-31.19M-22.90M-7.04M-15.21M
Financing Cash Flow381.90M399.21M68.39M6.45M301.11M1.24B
Net Cash Flow1.48B1.25B-340.85M311.47M454.94M282.45M
Free Cash Flow4.38B1.06B950.30M-297.74M351.34M-207.63M
Free Cash Flow Margin28.59%9.05%10.36%-5.08%8.86%-10.96%
Free Cash Flow Per Share14.954.033.58-1.341.65-1.16
Levered Free Cash Flow692.53M698.00M1.04B538.86M-230.88M-253.85M
Unlevered Free Cash Flow699.03M707.37M1.06B553.45M-217.46M-251.23M
Cash Interest Paid7.42M12.78M33.69M23.16M10.08M4.26M
Cash Income Tax Paid3.15M17.52M674.00K2.41M1.89M697.00K
Change in Working Capital3.74B1.46B838.86M-192.09M855.00M247.70M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization9.46B3.80B3.32B2.07B528.30M1.64B
Enterprise Value5.87B2.40B2.48B1.04B-1.21B568.00M
PE Ratio16.08130.51
PS Ratio0.600.330.360.350.130.87
PB Ratio4.563.873.272.560.591.18
P/FCF Ratio2.103.593.491.50
P/OCF Ratio2.083.473.391.39
EV/Sales Ratio0.370.200.270.180.30
EV/EBITDA Ratio8.5027.72
EV/EBIT Ratio8.8843.28
EV/FCF Ratio1.282.262.61
Debt / Equity Ratio0.230.510.370.470.430.07
Debt / EBITDA Ratio0.723.60
Debt / FCF Ratio0.110.470.391.09
Net Debt / Equity Ratio-1.75-2.32-1.14-1.85-1.32-0.73
Net Debt / EBITDA Ratio-5.466.19-12.907.272.051.91
Net Debt / FCF Ratio-0.82-2.15-1.215.01-3.354.88
Quick Ratio1.050.920.731.160.991.01
Current Ratio1.080.950.821.261.261.25
Asset Turnover1.742.102.171.441.010.68
Return on Equity (ROE)34.26%-44.35%2.87%-31.86%-53.35%-62.06%
Return on Assets (ROA)4.47%-4.44%0.85%-3.62%-9.40%-12.17%
Return on Invested Capital (ROIC)25.10%-27.62%3.47%-19.15%-42.75%-52.46%
Earnings Yield6.22%-11.67%0.77%-13.10%-114.76%-34.82%
FCF Yield47.67%27.86%28.63%-14.41%66.50%-12.62%
Buyback Yield / Dilution-17.37%1.30%-19.94%-4.32%-18.72%-511.57%